Leptin-induced endothelial dysfunction is mediated by sympathetic nervous system activity

• Published in: Journal of the American Heart Association 2013-09, Vol.2 (5), p.e000299-e000299
• Main Authors: Wang, Jintao, Wang, Hui, Luo, Wei, Guo, Chiao, Wang, Julia, Chen, Y E, Chang, Lin, Eitzman, Daniel T
• Format: Article
• Language: English
• Subjects: Animals; Blood Pressure; Endothelium, Vascular - drug effects; Endothelium, Vascular - physiopathology; Leptin - pharmacology; Leptin - physiology; Male; Mice; Mice, Inbred C57BL; Obesity; Original Research; Sympathetic Nervous System - physiology
• ISSN: 2047-9980; 2047-9980
• DOI: 10.1161/jaha.113.000299

The adipocyte-derived hormone leptin is elevated in obesity and may contribute to vascular risk associated with obesity. The mechanism(s) by which leptin affects vascular disease is unclear, although leptin has been shown to increase sympathetic activity. The aim of this study was to investigate the effect of leptin treatment on endothelial function and the role of the local sympathetic nervous system in mediating these effects. Recombinant leptin was administered to C57BL6/J mice every other day for 1 week. Mesenteric arteriole myography revealed that leptin treatment caused significant impairment of endothelium-dependent vasorelaxation. Although leptin alone did not raise aortic blood pressure, leptin treatment augmented the blood pressure response to angiotensin II. The effects of leptin on mesenteric arteriolar function and aortic blood pressure response to angiotensin II were neutralized following sympathetic denervation to the mesenteric vasculature. The superoxide scavenger TEMPOL was also effective in preventing the effects of leptin on endothelial dysfunction. Leptin causes endothelial dysfunction and enhances the effects of angiotensin II on blood pressure. These effects of leptin are mediated by sympathetic nervous system activation and superoxide and may contribute to vascular stiffness and hypertension in obesity.